News | January 12, 2022

Atlantic Health System Takes Consumer Convenience to the Next Level with Online Scheduling from KyruusNew Jersey-Based Health System Sees Increase in Online Appointment Bookings Boston, MA – January 12, 2022 – Kyruus, the leader in provider search and scheduling...

News | February 8, 2022

CLEERLY TAKES PRECISION HEART CARE TO THE NEXT LEVEL WITH CLEERLY 2.2.0Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease NEW YORK, February 8, 2022 — Cleerly, the company creating a new standard of care for heart...

News | February 2, 2022

CLEERLY NAMED TO NYC DIGITAL HEALTH 100 BY NEW YORK CITY HEALTH BUSINESS LEADERSOrganization recognizes the most promising and innovative health startups in New York NEW YORK, February 2, 2022 — Cleerly, the company creating a new standard of care for heart...

News | January 25, 2022

Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis —New Drug Application submission planned for second quarter of 2022— —Full data set to be presented at...

News | January 26, 2022

Sierra Oncology Announces Pricing of Upsized Public Offering of Securities SAN MATEO, Calif.–(BUSINESS WIRE)– Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today...

News | January 27, 2022

PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza VaccinePDS0202 (Infectimune™ + COBRA Influenza Antigens) neutralized multiple strains of the flu and provided effective protection against infection in preclinical studies FLORHAM PARK, N.J., Jan....